摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,4-diacetoxy-5-bromo-benzoic acid | 127450-30-0

中文名称
——
中文别名
——
英文名称
3,4-diacetoxy-5-bromo-benzoic acid
英文别名
Diacetyl-5-brom-protocatechusaeure;3,4-Diacetoxy-5-brom-benzoesaeure;3,4-Diacetyloxy-5-bromobenzoic acid
3,4-diacetoxy-5-bromo-benzoic acid化学式
CAS
127450-30-0
化学式
C11H9BrO6
mdl
——
分子量
317.093
InChiKey
LNCYHAZRXOLRHJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.6
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    89.9
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    3,4-diacetoxy-5-bromo-benzoic acid氯化亚砜叠氮基三甲基硅烷 作用下, 以 甲苯 为溶剂, 反应 4.33h, 生成 3-bromo-4,5-diacetoxyphenyl isocyanate
    参考文献:
    名称:
    Pharmacokinetics of catechol cephalosporins. The effect of incorporating substituents into the catechol moiety on pharmacokinetics in a marmoset model
    摘要:
    Two series of cephalosporins A and B have been synthesized, bearing at C-3' catechols substituted with various electron withdrawing groups (Y) and differing links (X), and were evaluated for their in vitro antibacterial activity and their pharmacokinetics in marmosets. Compounds in series A, bearing an isobutyric oxime substituent, proved to be highly active against Gram-negative organisms and were especially noteworthy for showing long elimination phase (beta) half-lives in marmosets. It was established that introduction of electron withdrawing substituents greatly increased the beta-half-lives of compounds (5, X = NHCO, Y = H, t1/2 = 1.25 h, AUC = 27 mg/h per L; 11, X = NHCO, Y = 5-Cl, t1/2, = 4.5 h, AUC = 638 mg/h per L) and that the nature of the link also influenced t1/2, the highest values being obtained when X = NHCO and OCO. Acidities (pK(a) values) of the substituted catechols were measured, and relationships between the acidities and half-lives were evaluated. Thus it was established that the more acidic catechols gave the longest half-lives (12, X = NHCO, Y = 2,5-Cl2, t1/2 = 8.2 h, AUC = 461 mg/h per L). Further elaboration of the catechol to bicyclic systems maintained good pharmacokinetics when the pK(a) was sufficiently acidic.
    DOI:
    10.1021/jm00092a015
  • 作为产物:
    描述:
    参考文献:
    名称:
    Zincke; Francke, Justus Liebigs Annalen der Chemie, 1896, vol. 293, p. 190
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Cephalosporins, process for their preparation and pharmaceutical compositions
    申请人:ZENECA LIMITED
    公开号:EP0341948A2
    公开(公告)日:1989-11-15
    Cephalosporin antibiotics having a 3-position substituent of the formula: -CH₂NR¹-Y-A-Z-Q are described, wherein R¹ is hydrogen or certain optionally substituted alkyl groups; Y is -CO- or -SO₂-; A is optionally substituted phenylene or heterocyclylene; Z is a linking group and Q is a catechol or related ring system. Processes for their preparation and use are described.
    具有式中 3 位取代基的头孢菌素类抗生素: -Ch₂nr¹-y-a-z-q 其中 R¹ 是氢或某些任选取代的烷基;Y 是 -CO- 或 -SO₂-; A 是任选取代的亚苯基或杂环基; Z 是连接基团,Q 是邻苯二酚或相关环系。 描述了其制备和使用过程。
  • PATHOGEN DETECTION
    申请人:University of Notre Dame Du Lac
    公开号:US20160319322A1
    公开(公告)日:2016-11-03
    A device for detecting bacteria in a sample, comprising: a substrate having a surface; and a plurality of Fe(III)-bound or Fe(III)-binding siderophores specific to the bacteria and covalently attached to the surface; wherein the siderophores are selected from the group consisting of one or more natural siderophores, siderophores having one or more of the formulas described herein, or combination thereof. Methods of detection are also provided.
  • REDUCTION-TRIGGERED ANTIBACTERIAL SIDEROMYCINS
    申请人:MILLER Marvin J
    公开号:US20160368878A1
    公开(公告)日:2016-12-22
    A compound is provided, comprising: an Fe(III)-binding or an Fe(III)-bound siderophore; one or more optional linker covalently bound to the siderophore; a drug; and an Fe(III) to Fe(II) reduction triggered linker bound to the drug and the linker or, if no linker is present, then bound to the drug and the siderophore. Compositions and methods including the compound are also provided.
  • US5055462A
    申请人:——
    公开号:US5055462A
    公开(公告)日:1991-10-08
  • US5149803A
    申请人:——
    公开号:US5149803A
    公开(公告)日:1992-09-22
查看更多

同类化合物

马来酰亚胺-酰胺-PEG8-四氟苯酚酯 马来酰亚胺-四聚乙二醇-五氟苯酯 马来酰亚胺-三聚乙二醇-五氟苯酚酯 靛酚乙酸酯 间氯苯乙酸乙酯 间乙酰苯甲酸 酚醛乙酸酯 邻苯二酚二乙酸酯 邻甲苯基环己甲酸酯 邻甲氧基苯乙酸酯 辛酸苯酯 辛酸对甲苯酚酯 辛酸-(3-氯-苯基酯) 辛酰溴苯腈 苯酰胺,3,4-二(乙酰氧基)-N-[6-氨基-1,2,3,4-四氢-1-(4-甲氧苯基)-3-甲基-2,4-二羰基-5-嘧啶基]- 苯酚-乳酸 苯酚,4-异氰基-,乙酸酯(ester) 苯酚,4-[(四氢-2H-吡喃-2-基)氧代]-,乙酸酯 苯酚,3-(1,1-二甲基乙基)-,乙酸酯 苯甲醇,4-(乙酰氧基)-3,5-二甲氧基- 苯基金刚烷-1-羧酸酯 苯基氰基甲酸酯 苯基庚酸酯 苯基己酸酯 苯基呋喃-2-羧酸酯 苯基吡啶-2-羧酸酯 苯基十一碳-10-烯酸酯 苯基乙醛酸酯 苯基乙酸酯-d5 苯基丙二酸单苯酯 苯基丙-2-炔酸酯 苯基丁-2,3-二烯酸酯 苯基4-乙基环己烷羧酸 苯基3-乙氧基-3-亚氨基丙酸盐 苯基2-(苯磺酰基)乙酸酯 苯基2-(4-甲氧基苯基)乙酸酯 苯基2-(2-甲氧基苯基)乙酸酯 苯基2-(2-甲基苯基)乙酸酯 苯基-乙酸-(2-甲酰基-苯基酯) 苯基(S)-2-苯基丙酸 苯基(2S,6S)-(顺式-6-甲基四氢吡喃-2-基)乙酸酯 苯基(2R,6S)-(反式-6-甲基四氢吡喃-2-基)乙酸酯 苯乙酸苯酯 苯乙酸对甲酚酯 苯乙酸-3-甲基苯酯 苯乙酸-2-甲氧基苯酯 苯乙酸-2-甲氧基-4-(1-丙烯基)-苯基酯 苯乙酸-2-甲氧-4-(2-丙烯基)苯(酚)酯 苯丙酸去甲睾酮 苄氧羰基-beta-丙氨酸对硝基苯酯